Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disordersPriscila Chiavellini, Martina Canatelli-Mallat, Marianne Lehmann, Rodolfo G.Goya, Gustavo R.Morel469-476
Pentadecapeptide BPC 157 and the central nervous systemJak?a Vukojevi?, Marija Milavi?, Darko Perovi?, Spomenko Ili?, Andrea Zemba ?ili?, Nata?a ?uran, Sanja ?trbe, Zoran Zori?i?, Igor Filip?i?, Petrana Bre?i?, Sven Seiverth, Predrag Sikiri?482-487
The short form of the SUR1 and its functional implications in the damaged brainIván Alquisiras-Burgos, Javier Franco-Pérez, Moisés Rubio-Osornio, Penélope Aguilera488-496
Promise of metformin for preventing age-related cognitive dysfunctionLeelavathi N.Madhu, Maheedhar Kodali, Ashok K.Shetty503-507
Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamineAngela De Iuliis, Ennio Montinaro, Giuseppe Fatati, Mario Plebani, Carlo Colosimo523-533
